DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0008043 | Chiari-Frommel Syndrome | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C4721610 | Carcinoma, Ovarian Epithelial | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0002170 | Alopecia | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C4083212 | Alopecia, Male Pattern | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0027708 | Nephroblastoma | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0345904 | Malignant neoplasm of liver | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0007103 | Malignant neoplasm of endometrium | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0005001 | Benign prostatic hypertrophy | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0238395 | Male Pseudohermaphroditism | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0524620 | Metabolic Syndrome X | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0014170 | Endometrial Neoplasms | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0004509 | Azoospermia | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0269102 | Endometrioma | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0238339 | Hereditary pancreatitis | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C1306459 | Primary malignant neoplasm | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0520477 | Prostatic Adenoma | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0019196 | Hepatitis C | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0036341 | Schizophrenia | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0039585 | Androgen-Insensitivity Syndrome | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0919267 | ovarian neoplasm | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C4049090 | Alopecia, Androgenetic, 1 | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0020514 | Hyperprolactinemia | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0032460 | Polycystic Ovary Syndrome | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024